• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Amylin Pharmaceuticals, Inc.: Company Profile and SWOT Analysis Product Image

Amylin Pharmaceuticals, Inc.: Company Profile and SWOT Analysis

  • Published: September 2011
  • 43 pages
  • iCD Research

Synopsis
ICD Research's "Amylin Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, competitor benchmarking data, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

ICD Research's "Amylin Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
- Examines and identifies key information and issues about Amylin Pharmaceuticals, Inc. for business intelligence requirements
- Studies and presents the company's strengths, READ MORE >



1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset, Liabilities and Capex
2.2.3 Net Debt vs. Gearing Ratio
2.2.4 Operational Efficiency
2.2.5 Solvency
2.3 Competitive Benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Capital Expenditure
2.3.4 Turnover - Inventory and Asset
2.3.5 Liquidity
3 Mergers & Acquisitions and Partnerships
3.1 M&A and Partnerships Strategy
4 Recent Developments
5 SWOT Analysis
5.1 SWOT Analysis - Overview
5.2 Strengths
5.3 Weaknesses
5.4 Opportunities
5.5 Threats
6 Amylin Pharmaceuticals, Inc. - Company Statement
7 History
8 Amylin Pharmaceuticals, Inc. - Key Employees
9 Key Employee Biographies
10 Locations and Subsidiaries
10.1 Head Office
10.2 Other Locations and Subsidiaries
11 Appendix
11.1 Methodology
11.2 Ratio Definitions
11.3 Disclaimer

List of Tables
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: Amylin Pharmaceuticals, Inc., History
Table 6: Amylin Pharmaceuticals, Inc., Key Employees
Table 7: Key Employee Biographies
Table 8: Amylin Pharmaceuticals, Inc., Subsidiaries

List of Figures
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Net Debt vs. Gearing Ratio
Figure 4: Operational Efficiency
Figure 5: Solvency
Figure 6: Market Capitalization
Figure 7: Efficiency
Figure 8: Capital Expenditure
Figure 9: Turnover - Inventory and Asset
Figure 10: Liquidity

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS